Third Quarter Summary Net income of $1.5 million compared to net income of $6.0 million in third quarter of 2013 Diluted earnings per share of $0.25 compared to diluted earnings per share of $1.27 in third quarter of 2013 Provision for loan losses of ($1.0) million, up $3.3 million from third quarter of 2013 Income tax expense of $1.1 million, up $0.9 million from third quarter of 2013 Net interest income of $4.8 million, down $0.5 million from third quarter of 2013 Non-performing assets of $13.8 million, down $2.0 million from second quarter of 2014 Year to Date Summary
ROCHESTER, Minn., Oct.
Sign-up for - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR investment picks
Third quarter production of 169.7 MMcfe/d exceeds high end of company guidance by 3%; represents a 32% sequential increase in average daily production over the second quarter of 2014 and 72% over the second quarter of 2013 Average daily production from oil, condensate and NGLs (including ethane) reached a record level of 10.4 MBoe/d, a 61% increase over the second quarter of 2014 Record oil and condensate production of 3.3 Mboe/d, a 20% increase over the second quarter of 2014 Full year 2014 production guidance increased by 2% at the midpoint of the guidance range
STATE COLLEGE, Pa., Oct.
Sign-up for - Rex Energy Provides Third Quarter Production Results, Increases Full Year 2014 Production Guidance, Updates 2015 Hedge Position and Announces Date of Third Quarter Earnings Release investment picks
Sign-up for - INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of LipoScience, Inc. of Class Action Against the Board of Directors of the Company Challenging the Fairness of the Sale of the Company to LabCorp -- LPDX investment picks
Highlights: Third Quarter 2014: Net Sales $339 Million, Value Added Revenue $180 Million Operating Income $33 Million; Adjusted EBITDA $41 Million; EBITDA Margin 23% Results Impacted by Two Unanticipated, Temporary Events: Process Refinement to Enhance Quality Attributes of KaiserSelect® Aerospace Plate Resulted in Higher Internal Scrap and Remakes of Plate Unplanned Downtime in Aerospace Sheet Operations Hampered Production Second Highest Quarterly Heat Treat Plate and Auto Extrusion Shipments Strong Manufacturing Cost Performance First Nine Months 2014: Strong Volume Growth in Aerospace and Automotive Applications Offset Pricing Pressure on Heat Treat Plate Significant Year-Over-Year Improvement in Manufacturing Cost Performance
FOOTHILL RANCH, Calif., Oct.
Sign-up for - Leading Cybersecurity Experts, CISOs, White House and U.S. Department of Homeland Security to Ring the Nasdaq Stock Market Closing Bell in Honor of National Cyber Security Awareness Month investment picks
Sign-up for - UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against AcelRx Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 1, 2014 -- ACRX investment picks
Sign-up for - INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Ambit Biosciences Corporation of Class Action Challenging the Fairness of the Sale of the Company to Daiichi Sankyo Company, Ltd. -- AMBI investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.